Ipsen’s Cabometyx Bounces Back With Promising Pivotal Prostate Cancer Results

In Combination With Tecentriq

read arrow in hands pointing up after downward curve
Cabometyx Has Made A Comeback With Positive Prostate Cancer Data • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D